-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 IyUXbE9wTCcgqLfLQoRk/sKpG2HVfW6M1RnNCZJ3L4SP4GV6BmAG4YbP0+wl18GE
 i1+WC608rI8+Sh4ksja5ew==

<SEC-DOCUMENT>0001019056-06-001168.txt : 20061222
<SEC-HEADER>0001019056-06-001168.hdr.sgml : 20061222
<ACCEPTANCE-DATETIME>20061222120637
ACCESSION NUMBER:		0001019056-06-001168
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20061221
ITEM INFORMATION:		Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20061222
DATE AS OF CHANGE:		20061222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DAXOR CORP
		CENTRAL INDEX KEY:			0000027367
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				132682108
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-09999
		FILM NUMBER:		061295725

	BUSINESS ADDRESS:	
		STREET 1:		350 FIFTH AVENUE
		STREET 2:		SUITE 7120
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118
		BUSINESS PHONE:		2122440555

	MAIL ADDRESS:	
		STREET 1:		350 5TH AVENUE
		STREET 2:		SUITE 7120
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IDANT CORP
		DATE OF NAME CHANGE:	19730823
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>daxor_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html>

<head>
<title></title>
</head>

<body bgcolor="white">




<hr size="4" width="100%" noshade color=black>


<p  align="center"><font size="2" face="Times New Roman"><b>UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION <br> Washington, D.C. 20549</b></font></p>
<p  align="center">
<font size="2" face="Times New Roman"><b>FORM 8-K <br> CURRENT REPORT</b></font></p>
<p  align="center">
<font size="2" face="Times New Roman"><b>Pursuant to Section 13 or 15(d) of <br> The Securities Exchange Act of 1934</b></font></p>
<p  align="center">
<font size="2" face="Times New Roman">Date of Report <br> (Date of earliest event reported)<br> <b>December 21, 2006</b></font></p>
<p  align="center">
<font size="2" face="Times New Roman"><b>DAXOR CORPORATION <br> </b>(Exact name of registrant as specified in this charter)</font></p>
<table align="center"  border="0" style="border-collapse:collapse" cellspacing="0"  cellpadding="0"  width="100%">

 <tr>
  <td width="32%" valign="top">
  <p ALIGN="CENTER">
<font size="2" face="Times New Roman"><b>NEW YORK</b></font></p>  </td>
  <td width="2%" valign="top">
  <p style="margin-left:1em; text-indent:-1em">
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td width="32%" valign="top">
  <p  align="center">
<font size="2" face="Times New Roman"><b>0-12248</b></font></p>  </td>
  <td width="2%" valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td width="32%" valign="top">
  <p  align="center">
<font size="2" face="Times New Roman"><b>13-2682108</b></font></p>  </td>
 </tr>
 <tr>
  <td  valign="top">
  <p ALIGN="CENTER">
<font size="2" face="Times New Roman">(State   or other jurisdiction<br>   of incorporation)</font></p>  </td>
  <td  valign="top">
  <p style="margin-left:1em; text-indent:-1em">
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p  align="center">
<font size="2" face="Times New Roman">(Commission<br>   File Number)</font></p>  </td>
  <td  valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p  align="center">
<font size="2" face="Times New Roman">(IRS   Employer<br>   Identification No.)</font></p>  </td>
 </tr>
</table>

<p  align="center"><font size="2" face="Times New Roman"><b>350 FIFTH AVENUE, SUITE 7120, NEW YORK, NY 10118<br> </b>(Address and Zip Code of Principal Executive Offices) </font></p>
<p  align="center">
<font size="2" face="Times New Roman">Issuer&#146;s Telephone Number: <b>(212) 244-0555</b></font></p>
<p  align="center">
<font size="2" face="Times New Roman">(Former Name or Former Address, if Changed Since Last Report) <br> <b>Not Applicable</b></font></p>
<p>
<font size="2" face="Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </font></p>
<table align="center"  border="0" style="border-collapse:collapse" cellspacing="0"  cellpadding="0"  width="100%">

 <tr>
  <td width="5%" valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td width="5%" valign="top">
  <p>
<font size="2" face="Wingdings">o</font></p>  </td>
  <td width="90%" valign="top">
  <p>
<font size="2" face="Times New Roman">Written communications   pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></p>  </td>
 </tr>
 <tr>
  <td  valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
 </tr>
 <tr>
  <td  valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p>
<font size="2" face="Wingdings">o</font></p>  </td>
  <td  valign="top">
  <p>
<font size="2" face="Times New Roman">Soliciting material   pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>  </td>
 </tr>
 <tr>
  <td  valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
 </tr>
 <tr>
  <td  valign="top">
  <p><font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p>
<font size="2" face="Wingdings">o</font></p>  </td>
  <td  valign="top">
  <p>
<font size="2" face="Times New Roman">Pre-commencement   communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR   240.14d-2(b))</font></p>  </td>
 </tr>
 <tr>
  <td  valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
 </tr>
 <tr>
  <td  valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p>
<font size="2" face="Wingdings">o</font></p>  </td>
  <td  valign="top">
  <p>
<font size="2" face="Times New Roman">Pre-commencement   communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR   240.13e-4(c))</font></p>  </td>
 </tr>
 <tr>
  <td  valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
 </tr>
 <tr>
  <td  colspan="3"  valign="top">
  <hr size="4" width="100%" noshade color=black>

  </td>
 </tr>
</table>

<p> <H5 style="PAGE-BREAK-BEFORE: always" align=left></H5>
<p>
<font size="2" face="Times New Roman">Item 5.02 (c)&nbsp;&nbsp;Appointment of Chief Operating Officer and Chief Financial Officer</font></p>
<p align="justify">
<font size="2" face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On December 21, 2006, the registrant announced that Stephen Feldschuh, current Chief Financial Officer and Vice President of Operations will be assuming the newly created position of Chief Operating Officer. The registrant has not appointed a new Vice President of Operations and there are no plans at present to do so. On the same day, the registrant also announced that David Frankel, the current Treasurer will become Chief Financial Officer. These changes will be effective on January 1, 2007.</font></p>
<p align="justify">
<font size="2" face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr. Feldschuh was Director of Operations from November 2001 through January of 2003 before assuming his current position as Chief Financial Officer and Vice President of Operations. Stephen Feldschuh is the son of Dr. Joseph Feldschuh, the President and Chief Executive Officer of Daxor.</font></p>

<p align="justify"><font size="2" face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compensation for Mr. Feldschuh consisted of an annual base salary of $150,000 and participation in the Company&#146;s bonus pool. He is also eligible to participate in the Company&#146;s Stock Option Plan. His salary for 2007 has yet to be determined.</font></p>
<p align="justify">
<font size="2" face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr. Frankel joined the firm in November 2005. Prior to that, he was the Controller of Stern Stewart &amp; Co. a multi-office International Financial Consulting firm from March of 1997 through August of 2004. He also served as Controller of Strategic Work Force Solutions, a firm in the staffing industry from August 2004 through November 2005.</font></p>
<p align="justify">
<font size="2" face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compensation for Mr. Frankel consisted of an annual base salary of $95,000 and participation in the Company&#146;s bonus pool. He is also eligible to participate in the Company&#146;s Stock Option Plan. His salary for 2007 has yet to be determined.</font></p>
<p align="justify">
<font size="2" face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A copy of the News Release issued by the registrant on December 21, 2006 is attached to the report as Exhibit 1 and is incorporated by reference.</font></p>
<table align="center"  border="0" style="border-collapse:collapse" cellspacing="0"  cellpadding="0"  width="100%">

 <tr>
  <td  valign="top">
  <p style="margin-left:1em; text-indent:-1em">
<font size="2" face="Times New Roman">Item 9.01</font></p>  </td>
  <td  valign="top">
  <p style="margin-left:1em; text-indent:-1em">
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  colspan="2" valign="top">
  <p>
<font size="2" face="Times New Roman">Financial   Statements and Exhibits</font></p>  </td>
 </tr>
 <tr>
  <td  valign="top">
  <p style="margin-left:1em; text-indent:-1em">
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p style="margin-left:1em; text-indent:-1em">
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  colspan="2" valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
 </tr>
 <tr>
  <td  valign="top">
  <p style="margin-left:1em; text-indent:-1em"><font size="2" face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)</font></p>  </td>
  <td  valign="top">
  <p style="margin-left:1em; text-indent:-1em">
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  colspan="2" valign="top">
  <p>
<font size="2" face="Times New Roman">Exhibits</font></p>  </td>
 </tr>
 <tr>
  <td width="10%" valign="top">
  <p style="margin-left:1em; text-indent:-1em">
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td width="2%" valign="top">
  <p style="margin-left:1em; text-indent:-1em">
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td width="5%" valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td width="83%" valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
 </tr>
 <tr>
  <td  valign="top">
  <p style="margin-left:1em; text-indent:-1em">
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p style="margin-left:1em; text-indent:-1em">
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p>
<font size="2" face="Times New Roman">99.1</font></p>  </td>
  <td  valign="top">
  <p align="justify">
<font size="2" face="Times New Roman">News Release   dated December 21, 2006, announcing the appointment of Chief Operating   Officer and new Chief Financial Officer.</font></p>  </td>
 </tr>
</table>

<P>
<HR noShade>
<P>
<H5 style="PAGE-BREAK-BEFORE: always" align=left></H5>
<p  align="center">
<font size="2" face="Times New Roman">Signatures</font></p>
<p align="justify">
<font size="2" face="Times New Roman">Pursuant of the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<table align="center"  border="0" style="border-collapse:collapse" cellspacing="0"  cellpadding="0"  width="100%">

 <tr>
  <td  valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  colspan="2" valign="top">
  <p>
<font size="2" face="Times New Roman">Daxor   Corporation (Registrant)</font></p>  </td>
 </tr>
 <tr>
  <td width="60%" valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td width="4%" valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td width="36%" valign="top">
  <p>
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
 </tr>
 <tr>
  <td  valign="top">
  <p><font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p><font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p><font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
 </tr>
 <tr>
  <td  valign="top">
  <p><font size="2" face="Times New Roman">December 21,   2006</font></p>  </td>
  <td  valign="top">
  <p><font size="2" face="Times New Roman">By:</font></p>  </td>
  <td  valign="top">
  <p><font size="2" face="Times New Roman">/s/ Joseph   Feldschuh, M.D.</font></p>  </td>
 </tr>
<tr>
<td></td>
<td>
</td>
<td><HR COLOR="BLACK" SIZE="1" ALIGN="LEFT"></td>
</tr>
 <tr>
  <td  valign="top">
  <p><font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p><font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
  <td  valign="top">
  <p><font size="2" face="Times New Roman">Joseph   Feldschuh, M.D., President and Chief   Executive Officer</font></p>  </td>
 </tr>
</table>

<P>
<HR noShade>



</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>

<head>
<title></title>
</head>

<body bgcolor="white">




<p  align=right><font size="3" face="Times New Roman"><b>Exhibit 99.1</b></font></p>
<table align="center"  border="0" style="border-collapse:collapse" cellspacing="0"  cellpadding="0"  width="100%">

 <tr>
  <td width="100%" valign="top">
  <p align="justify">
<font size="2" face="Times New Roman"><img src="image_001.gif" alt="Message" width="258" height="145"></font></p>  </td>
 </tr>
 <tr>
  <td  valign="top">
  <p align="justify">
<font size="1" face="Times New Roman">&nbsp;</font></p>  </td>
 </tr>
 <tr>
  <td  valign="top">
  <p align="justify">
<font size="3" face="Times New Roman"><b>Daxor   Announces the Promotions of Stephen Feldschuh to Chief Operating Officer and   David Frankel to Chief Financial Officer</b></font></p>  </td>
 </tr>
</table>

<p align="justify">
<font size="2" face="Times New Roman">New York, NY - December 21, 2006 - Daxor Corporation (AMEX:DXR), a medical instrumentation and biotechnology company, today announced the promotions of Stephen Feldschuh to Chief Operating Officer (COO) and David Frankel to Chief Financial Officer (CFO).&#160; Stephen Feldschuh was the CFO and VP of Operations and will assume the newly created position of COO.&#160; Stephen worked for Daxor from 1992 to 1997 in various roles in operations.&#160; He left the Company to earn his MBA in Finance.&#160; He worked for two public companies before returning to Daxor in 2001.&#160; In 2003 he was promoted to CFO and VP of Operations. Stephen has been responsible for a major change in the organization and the structure of the Company with respect to significant improvements to the BVA-100 distribution, manufacturing and product development. In his new position, Stephen will be focusing on the macro view and driving to achieve the long range goals for Daxor.</font></p>
<p align="justify">
<font size="2" face="Times New Roman">Mr. Feldschuh will relinquish his title of CFO which will be filled by David Frankel who was previously the Company&#146;s Treasurer.&#160; David joined the Company in November 2005, and has been instrumental in restructuring the financial reporting, accounting systems, and laying the ground work for Sarbanes-Oxley 404 compliance.&#160; David earned his undergraduate degree from Hofstra University and has been a CPA since 1985.&#160; In addition to his public accounting experience, David has held various positions in the financial consulting and staffing industries.&#160; In his promoted role of CFO, David will be completing his work on the 404 compliance as well as budgeting, forecasting and expanding the financial analysis for Senior Management and the Board of Directors.</font></p>

<p align="justify"><font size="2" face="Times New Roman">Dr. Joseph Feldschuh, Daxor&#146;s President and CEO said &#147;I am very pleased with the work of both these individuals and look forward to the improvements they will bring in their new capacities.&#148;</font></p>
<p align="justify"><font size="2" face="Times New Roman">Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with Volumex, Daxor&#146;s single use diagnostic kit.&#160; </font></p>
<p align="justify"><font size="2" face="Times New Roman">For more information regarding Daxor Corporation&#146;s Blood Volume Analyzer BVA-100, visit Daxor&#146;s website www.Daxor.com.</font></p>
<p><font size="2" face="Times New Roman">&nbsp;</font></p>
<p align="justify"><font size="2" face="Times New Roman">Contact Information:&#160; Stephen Feldschuh, 212-330-8515 (Chief Operating Officer) stephen@daxor.com or Diane Meegan, 212-330-8512 (Investor Relations) dmeegan@daxor.com.</font></p>
<p align="justify">
        <HR noShade>

</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.gif
M1TE&.#=A`@&1`'<``"'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`"P`
M`````@&1`(4``&8``)D`,V8(*H@9.X@S,V8S,YDJ1)D[59DS9IDS9LQ5;JI,
M9JIF,YEF9IEF?[MF9LQFF9EWB+MFF<R99LR9F9F`D<R1HLR9S,RSN]VBL]W,
MF<S,S,S=W=W5U>[$S.[,_\S,____S/_N]__N[N[___\!`@,!`@,!`@,!`@,!
M`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!
M`@,!`@,!`@,!`@,!`@,!`@,!`@,&_\"2<$@L&H_(I'+);#J?T*AT2JU:K]BL
M=LOM>K_@L'A,+IO/Z+1ZS6Z[W_"X?$ZOV^_XO'[/[_O_@(&"@X2%AH>(B8J+
MC(V.CY"1DI.4E9:7F)F:FYR=GI^@H:*CI*6FIZBIJJNLK:ZOL+&RL[2UMK>X
MM!^YO$T<$KW!21\)PL9%%P/'RR4+`KO,P@0#P-&]&0(#!M:]#P/3)-RYV0,"
M%^*WR0/K".BV!N3K'NZS'.OPWP[TLM[QVB/[7GWP-\U<0%<'UI7#]^T@*W4"
M#"A<)Z":PU,#%9*+9P#@15,2%TX,:?`C*0??**XK4$XA@7DF0VE(Z6\B.7TQ
M/]DC)S$BN?]IZZ9QR-G)`U"5$T6V5$94TX=I!>_]1*IP05-,'QA&U$AR8M1S
MK3YP$$MVK-D/'E=Y$'"4JE)\/PT,]>1!H\V[2?.V3+#@`DPK(1PD2""8\.#"
MB`\G^%O$@H0+%QQ#?GQ!06(&"Q@/06FW,])P)8P"]7D/+\>6"-(>.9#8L&O!
M"0<DCAV1`0,'CS^`?F/O:#P"_C8BK=GR`%@J%P*TU:OW`1($V:*W%$"\7#%D
M*D>[]&>UQ%.7=TEKR\8PZ(#N2)@SKYXMJDH!$.:ZV1ARN7WS%'MV%3"!BG3U
MZR%1EWKE390!$2/@LUQ*YD4T1`)+T0=@9S<E45U>"^+GU5T)J*;_1E+T">?>
M4IYQY&`4%_B&SXKDM:C0<=B-AQ=<*Q)Q03RD%1@4-"QJ0Z%6#(6$GP;I+>2B
M5D&Y^-.2>LG5AGA*Y3<2>4;Z.&50!$#C!$E"4ECB-D@XD]]67'EU7(;QL.13
M-1(LR-8`&X@E9$09?)"!?AL)=427))*I'XE=FFC72VQ<N51/5;JU%$L@:O,$
M-KY)6=I;[<%81%["#>=H"0^$6%I-8&*0Z41$"A$"F0<*(2IS!'A80@+EE?=?
M4C1^:B@![:SAF947*J0C@\%=QP1G-G75)U4,))'!`(S26B9P$Y`@Z:X4$4E"
ME_`P)%\)&ETJDGC";C8F<TB2.)V7&EEJ_P:5[QDJ'D\N*M7L`.H:$<*8<UHI
MU97/)(%20=E&EZ\V$2B'5)`M0B"$F,QB>)P(\<BW++7T%@%A7HP6R">9OG(<
MJZ[O"0ED7HBZQ1X3$-047*+[*H33$0D"*.@W,]]%@!#VZ$7?@1\@,-(N'`2L
MKT\W$[$`5RM':&3)[U)54*EHM#3GKYXV^9NY+R.QE:!\=KQAJTE@D*@_!2:]
M4E*I^LPR0PZ(]<MT\8W%P(SQ9`WAO#1;&:2YY.+XXH<40\DQTB7+RI"K0Z@S
M[G#E-EUOXLY"2:F0ODW3W<28!I5U"1=(Y%Q:*>,U40A#0#!AA`;P=<$"#&3+
MLJ0]%8W&Q3):#?^C!QDX$)NY\;KTN+0\D6OH2/<H(4("HQ9+5?+%"X$\0\!U
M23H1)&1SQ+Y`PI=X>SF"JK`1%I"M\E+AFN'`NWA2%,#CH4_K*U=(B&V7IV2R
M5PYPJ2+QP;2"8^JZD6"1EJ02L+J%'*%U1T").4P7)0%`+G-G*\?C%$>B9@EI
M<V5(@,%$IZ#'E>!?2`L9.:97!*%-*BD2>%Z5=)0L)2@.2K$*GEO0<Z-B#4$B
MY1."8(X`H;D0BR=@J2$,:^+!&,Y/(3DD@P,`=AH<661/?!L<1=1%P:V-3004
M[,R<=H,$JC4*+DD!C@ANJ"\"@.E5YSF"!5IHL0%`PP(`H\AULE@[FWC_<'$,
MZA(&R4"[?1''@R40&]5BA4&&$4@`Q:@>'LWUQ"/L#V%><PN+8"2=C9SC1@:H
M%P:2B!('C(`$:J.*$"H0@*8M[G<Z8UQ)T,"9Y.$)D"60(=[@1X2<-=!88$E9
MH+C4'B9(P#.U<M>FA/"=TN!JC"6`1[T^L,<$$(!('NC'^P2P@1),`$V4`\#C
M?.:W/TU$2V>XF!']`4L(S6I1YFEC]F`'N2;J!98E4%NY%D<0<&*C727P2`@"
ML*TA>"")!"2"`:)"#@MPSE,E"\H%.@`-#W#@`4`)6$)SM`8%1M(KVEP"!?3E
M/G(084`3RD;6`B4IGYPQ"77IU?N\LCG%D:0(__WB(0^W-0%VK<,J=$1==!Y@
M4;--J)]FZ*/X7-)((]1TA=GIUF:8N$A"B4MR42(`4(V0G.XA"5[KH.HY+Y4$
MYQBA?%7E2C$PJ=)U)&!_HE-:[;+A537H,I)*@F5.+P2-$"R'8UL[:0ELZ3[R
M#<MORJ,0.#EG*Z8,079&V*->.9!7L^Z5<-]*20-B&3F1.4VOLRLEWZ@B5QSU
MB$4P:66C!K596U5GL#&:YJ1RA$1D`.`H\+!85XW@`3824U/ZV)]/79*L@9+&
M;P([V_?8P+`_<8P`&57"T1J6RI8(08`*L6"4&O7;2:FI)^B!8OW\F#GDPDBW
M2"E"=HLP`;VFS@AZ*?]&SKHVKK%.B"1`F>KL)NH6`L!RH&FMHP[CJ*C^K0>"
MADTL\U16(#T]%U-%.`!AM/1/!\!#2_90%XLDDMO_,&J6^A"@27OW-SB<CV0E
M+2KUHA+1US'%30,+;%NV"UL).E)#S"T3K=H38(D*(`#>&H!\^"J?@:B+=C<V
M"%K7`ST=-I=$252#."N)%T#64%-)8<E8!_P_P=%HJ.<:)A$8E+>+`E8EZ"'6
M-PCPLO9I*2/K.+..$VN>:1QHO5/)G!!F0K8(:LO#5#&N1)+;1>+5KSSZF)(7
M5RHS9TVQ,?_!Z[0R%IQ282!2AG7F.GJLDATK9"Y5I,AMI98G21TV?69K:QO_
MQ%G:,7OP7Y*3X@`L\&0LP_5@1QI7\$[:`2[+.+`J69$V2"<"X'CEJ6X<`E_/
M3`YH2(!K.)M120TKYC"VC(L5/=BQRB'BX]F:=Q012E\]&YR0R(IB[\'`#:?2
M+`GE]SW7\0:P'G3I(>POONYN-V&10@"#>@=0LXK'$#*@G;$%A<]L$"KV)K*`
MN8SE`L@;4<M6:@`XAG#A97*EU#A=1S`E0^%P->)T,UD"12[E0?B`\%)$GF8A
MU+`KH('SC)-"!!D2KR4$.,`;8!6\;MO/?S4'8P1^-;((ZH517ZZOCE/J;*C2
MTU@M&0H#0T+&==B[!)A;)412E0SIG/>V-B^6`TN7_^7J:@1J:]"@PE.=YS2-
M-B\OG&=_(3YPUHJG=36+LC8R-/%X7$=-ZQ#W/1<B[J!%E``'NA,Y%'8M$)'\
MD`JQD9]`%8_QIN%H?\[<QL#S)1Q!I&\30<`"'`"9SG?>`IL'\ME)F^NJ(0!X
MMY:4=^?]*Q*Y)U/5]4?6T'KA10K@+]#->E+DF\'E&9H<\Q+/-'[%$@.\=:V0
M#/`2V(LAN9<^*>)6MQ7K^),L-:-/NM9+6S(D-!&DA:^(!R=^+QI![04\8],$
M(XC8Z^H!8`!1YNY,DH\`$3VS[$TR`Q/$$HI]6G+)--D&90^W#I8R9/AG2FOV
M0$:'4224!J)W3BW3;QR&-__F\&34=R75Y`00(X!Q%STSDS^_-!&SM!33``Q9
MH2CZLC<R$CT@,ES"AA_M-UC$`70*\@TB5@;--C0CPW@=A0\/4'CY]Q-1<'R\
M8BS3MUJ.-00)PAZ44VDE``+_%WOA<79L@5GW!BB,,VE%T$JM%R$!)R-7IC,A
M,8+5<0ZA(QX],A$NZ`L".%W4U3&#I0XL$4=!5S0GR#==8D$<EH1&H'*'<A=@
M5P(S$48PU&%I8%&E178_TB"R`0W$P3SEP'M)X&W;%H6\E$9&D&+194SKT$(=
MT$<B]%\^$A'S!UX-U"?JLEVI5(5A]U[#$U%?!@$=("ZU8UEH.`5"A"[3IA?(
M5`3_O9%?3%8Q1A9C15<VAG@$X(=4,J(NQ14B98-:?.1-UY5H_",5!K``\5$$
MQ:0DBD)F5*`BZ5=2LN)![6.-Q($H\I$B>11TDE)P2X!6JI8GZT-5=L%>0N)X
M9$`69)$!%L!JGO>/`$D6+N0`#$`8V,)M`Z`93[!$6E<L$"(8$&`8$`EM1!`"
M`'D!E/&/$N"/<8@\'7.)(9$`DC@$)-!Y$.``?0&0$>D`X@8^GI>1GA<!9#&+
M5S$&6.1@BH(`G->+-?D)'D`6/-F30CF41%F4N=!Y$B")(H`!&`D9%'D69M&`
M>U468J$$'#`9%Y`__@2557D$(G`6&3`60A"65,D!9N$!_QT0EFII!"2P`1-P
M`15P`4$)=6;ABU3)"N55#II%+PD``!_5*4'6$@Y`0LN"(YIE$9BB'**V5VI3
M21>P&W-E`%II36%D4'RU,A8@5%K94W+T%WSU1$BV"O`@``Y@`1Q@`<0B.QP`
M%!!P`5<9.D[2<1.0,@?0CYU3@B;W2P+0CYF9#<(R`??`>1]PF_^`,Q,`(0G`
M:@_0$^!TE0SAFO>621+@#08P`1;@#9T'#YP'$SE#``0TG,ME`"WY`180`0JA
M)=>I#9"A"L\S6!Z`#T+PGA%!D_[D,T[U6.&2(@!`0EDU!!NP#D3RGP*P`![R
M?@*0*R:W2B/@,YAE'G,Q$-<!H?_$5!)'TQ]D9'U$8&TQ=86(1`02J@KJ`(WR
MZ3S]>033("S[DUW2(E5#8#U$<``&<5-(H(['D1PP(C9;MSTG.0!>90\XX:,X
M,X]H=!QBHI`=)Q'H80\A86GX2`K.M$=",#<E(`+?X$$UE'(#$"[`HR4E2J*0
M40YS^2`G0E@58"-=6@)S@P&]X6[0L#_7,0(<0),+P&??\'1&@*,PX:8A&&_S
M)PKK,)DV<@ZKL@0$.*%9PQF]>*;*Y`QK6`3+0@#3<VS'(9_A$@*OE4_3H"Y`
M^E7"6'7+)XQ`"AS?LZFHD!$4255FM`3G`Q:/-!C+Q1];EJ,CP!G,!*M*<&-S
M80':8!C_;P).R=`=O^1X;GH$<QI$J:H$#WE;[K5FPYH*:-4$O]2GKR*DR=@7
MWK(`L`(4!@4AL%0.T&"!VI`9)20`I;(6RH>?/&1?)@<`ML5#`]!"]G`=#.`@
M\:H*M9:`2A`^5D@$R,.J6=HYMW<]"X&M$S`7*=.H'Z6%G+,^<V.%)'"B@K%<
M=GIOG%01)M<02G`^U="LO;9J^P.EH^!B2_"H4IFAA?I8^H"<1^"BB>6=+E2B
M%4`O'0`<116"\N>+LL%#0GI/1CH$R@$6FSH"-26>`2"MH(`2,C>C8$%A20"<
M.3JL(@`/C7JF^Z:P>W)U)1`^_:$._:1,8`D/C-&L6[A*"0&R_U6'3&*;3!'A
MLJJ`5O520^)V;,*(LP)``2\X1][J+4G@,TG+9ANJJV!Q-'WK'6-Z0P3P1*3*
MKW-;0X&8;.:'LAXJF*R@FXM97H\+(8?;&.R0%F+[+Y>2HT:0%6P!(X&Q#D]T
M(V"QA&ST2XMY4(/[`46;0-2@N)EK(].0&GQ:!.IFM*'02H;1$I9B3EE*&"V!
M'L0P4*D##",0/02$K3<54'V8$JE#<S:8.+"RJ^<PB(<Q?(OQ(!=#0!HP&*0X
M7"ET#]UK9+XI&$"!H,=+`-[Y1-,`LJ40-#:1C49P)TD!O?&)DH>QL0E@&QL@
MD831N$-@`=!C``^P+1<@&`S<DA+`P&^&@:U_`<$.D`$++!BW81$KB:WNN&\,
MA$3?Q;^$@;@)T+JK()!,4)=G(!8].P<J;)0P',,R/,,T7,,V?,,XG,,ZO,,\
MW,,^_,-`',1"/,1$7,1&?,1(G,1*O,1,W,1._,10',52/,547,56?,5!'`0`
!.S\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
